Centro de Investigación Biomédica en Red Enfermedades Raras;Universidad Autónoma De Madrid (UAM);Consejo Superior de Investigaciones Cientificas (CSIC)
发明人:
申请号：
EP15872009.4
公开号：
EP3239133A1
申请日:
2015.12.17
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
The present invention relates to a group of compounds with a structural nucleus derived from phenylacetamide, having the following formula (I):that can modulate the DREAM neuronal calcium sensor. Consequently, the present invention also relates to the use of these compounds for the treatment or prevention of disorders or diseases in which DREAM levels are above or below physiologically normal levels.
